No Data
Asukanet To Go Ex-Dividend On April 28th, 2025 With 7 JPY Dividend Per Share
April 25th (Japan Standard Time) - $Asukanet(2438.JP)$ is trading ex-dividend on April 28th, 2025.Shareholders of record on April 30th, 2025 will receive 7 JPY dividend per share. The ex-dividend
Asukanet: Extraordinary Report
Information on individual stocks.
Note <5243.T> announced the first-quarter financial results for the November period (last December to this February), showing a consolidated operating profit of 5 million yen (compared to a loss of 7 million yen in the same period last year), achieving profitability. The core Broadcasting platform business is growing significantly. The full-year financial estimates remain unchanged, expecting an operating profit of 60 million yen (up 13.5% from the previous period). The stock price has fallen back. Astroske <186A.T> remains strong. Comprehensive Task Center development and operational verification for the fuel supply satellite APS-R.
Asukanet has fallen, revising its Financial Estimates for the fiscal year ending April 2025 downward, leading to a shift to reduced profits.
Askanet <2438.T> has fallen, temporarily dropping 33 yen to 370 yen. After the close on the 8th, the consolidated performance forecast for the fiscal year ending April 2025 was revised downward, causing discontent. In the 2025 fiscal year performance forecast, revenue was lowered from 7.72 billion yen to 7.257 billion yen (a 3.1% increase compared to the previous period), and operating profit was reduced from 520 million yen to 176 million yen (a decrease of 60.6% compared to the previous period), forecasting a decline in profit. The funeral business is progressing smoothly, but the photobook business is operating as its main focus.
Qualips, Ecomot, and others.
＜2438＞Asukanet has revised its downward forecast, with the full-year operating profit projected at 0.176 billion yen, down from 0.52 billion yen. ＜3987＞Ecomott has revised its performance expectations, with the operating profit for the first half now forecasted at 0.044 billion yen, up from 0.042 billion yen. ＜4894＞Qualips has applied for manufacturing and sales approval for cardiac muscle cell sheets derived from iPS cells of the same type. ＜5595＞QPS Institute has begun the large exercise of the 8th subscription rights (with exercise price adjustment clauses), with the number of shares to be delivered starting from the 8th being 1.17 million shares.
Dai Seki, operating profit for 25/2 decreased by 3.3% to 14.3 billion yen, Financial Estimates for 26/2 increased by 9.6% to 15.7 billion yen.
The financial results announced by Dai Seki <9793> for the period ending February 2025 showed that revenue decreased by 2.7% compared to the previous period, amounting to 67.34 billion yen, while operating profit fell by 3.3% to 14.318 billion yen. Although the large-scale projects for the removal of buried waste and contaminated soil that drove the previous year’s performance have concluded, there has been an acquisition of high-value-added project orders, such as large-scale contaminated soil treatment and construction projects in the Kanto region, which are expected to continue into the next period. For the fiscal year ending February 2026, revenue is expected to increase by 4% compared to the previous period, reaching 70 billion yen, and operating profit is